Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
3(60%)
Results Posted
100%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_2
1
20%
Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(1)
Terminated(1)

Detailed Status

Recruiting2
Completed1
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (20.0%)
N/A4 (80.0%)

Trials by Status

completed120%
active_not_recruiting120%
recruiting240%
terminated120%

Recent Activity

3 active trials
Showing 5 of 5
recruitingnot_applicable

Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma

NCT07337161
active_not_recruitingnot_applicable

Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer

NCT02474641
completednot_applicable

Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer

NCT02528175
recruitingnot_applicable

Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

NCT05665920
terminatedphase_2

Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy

NCT00765570

Clinical Trials (5)

Showing 5 of 5 trials
NCT07337161Not Applicable

Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma

Recruiting
NCT02474641Not Applicable

Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer

Active Not Recruiting
NCT02528175Not Applicable

Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer

Completed
NCT05665920Not Applicable

Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

Recruiting
NCT00765570Phase 2

Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy

Terminated

All 5 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
5